1. Home
  2. CPSS vs MCRB Comparison

CPSS vs MCRB Comparison

Compare CPSS & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$7.72

Market Cap

165.8M

Sector

Finance

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$9.15

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
MCRB
Founded
1991
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.8M
139.7M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
CPSS
MCRB
Price
$7.72
$9.15
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
15.9K
42.7K
Earning Date
03-10-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
1.27
N/A
EPS
0.80
0.64
Revenue
$434,470,000.00
$789,000.00
Revenue This Year
$147.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.73
$13.75
Revenue Growth
10.41
N/A
52 Week Low
$6.67
$0.36
52 Week High
$10.51
$29.98

Technical Indicators

Market Signals
Indicator
CPSS
MCRB
Relative Strength Index (RSI) 44.93 44.79
Support Level $7.47 $7.74
Resistance Level $8.57 $9.53
Average True Range (ATR) 0.31 0.68
MACD 0.02 0.17
Stochastic Oscillator 30.34 56.90

Price Performance

Historical Comparison
CPSS
MCRB

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: